InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Kevin Balthaser, Chief Financial Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 3 open-market SEC Form 4 transactions: 1 purchase worth $75K and 2 sales worth $24K, reported from Mar 2, 23 to Sep 6, 23. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 6, 23 | ACRSAclaris Therapeutics, Inc. | BUY | 9.5K | $7.90 | $75K |
| Mar 3, 23 | ACRSAclaris Therapeutics, Inc. | SELL | 894 | $12.63 | $11K |
| Mar 2, 23 | ACRSAclaris Therapeutics, Inc. | SELL | 1.0K | $12.29 | $12K |